Clinical trial · Observational
Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer
Clinical Trial to Access Significance of Fluorescence Colposcopy With Autofluorescence Imaging for the Screening of Cervical Cancer
NCT01854983CI-TRIAL-00027897completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence imaging for the screening of cervical cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- fluorescence colposcopic result
- timeFrame
- 2weeks after fluorescence colposcopy
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. age : 20-65 years 2. abnormal cervical papanicolaou smear , no other specific cervical disease 3. subject to colposcopic biopsy or LEEP 4. signed voluntarily to informed concents with full knowledge after explanation abot objective, method, contents Exclusion Criteria: 1. pregnant women 2. porphyria 3. severe cervical bleeding 4. genital chlamydia, gonorrhea infection 5. other drug user with possible interaction (e.g. photosensitizer) 6. no informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.